126 related articles for article (PubMed ID: 10471042)
41. A chimeric fusion of the hASH1 and EZH2 promoters mediates high and specific reporter and suicide gene expression and cytotoxicity in small cell lung cancer cells.
Poulsen TT; Pedersen N; Juel H; Poulsen HS
Cancer Gene Ther; 2008 Sep; 15(9):563-75. PubMed ID: 18421308
[TBL] [Abstract][Full Text] [Related]
42. Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium.
Gross AJ; Steinberg SM; Reilly JG; Bliss DP; Brennan J; Le PT; Simmons A; Phelps R; Mulshine JL; Ihde DC
Cancer Res; 1993 Jan; 53(1):67-74. PubMed ID: 8380126
[TBL] [Abstract][Full Text] [Related]
43. Osmotic and non-osmotic regulation of arginine vasopressin (AVP) release, mRNA, and promoter activity in small cell lung carcinoma (SCLC) cells.
Kim JK; Summer SN; Wood WM; Schrier RW
Mol Cell Endocrinol; 1996 Oct; 123(2):179-86. PubMed ID: 8961255
[TBL] [Abstract][Full Text] [Related]
44. Efficient lipofection with cisplatin-resistant human tumor cells.
Huang L; Son K; Gao X; Hages D; Yang YY; Holden SA; Teicher B; Kirkwood J; Lazo JS
Cancer Gene Ther; 1996; 3(2):107-12. PubMed ID: 8729909
[TBL] [Abstract][Full Text] [Related]
45. miR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells.
Zhao H; Zhu L; Jin Y; Ji H; Yan X; Zhu X
Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):177-82. PubMed ID: 22172490
[TBL] [Abstract][Full Text] [Related]
46. Enhanced expression of apoptin by the Myc-Max binding motif and SV40 enhancer for SCLC gene therapy.
Song JS
Biosci Biotechnol Biochem; 2005 Jan; 69(1):51-5. PubMed ID: 15665467
[TBL] [Abstract][Full Text] [Related]
47. Use of RT-PCR to detect co-expression of neuropeptides and their receptors in lung cancer.
Ocejo-Garcia M; Ahmed SI; Coulson JM; Woll PJ
Lung Cancer; 2001 Jul; 33(1):1-9. PubMed ID: 11429190
[TBL] [Abstract][Full Text] [Related]
48. Differential utilization of the SV40 enhancer and early promoter in various human lung carcinoma cell lines.
Wong YC; Bernal SD
Int J Cancer; 1990 May; 45(5):911-5. PubMed ID: 2159440
[TBL] [Abstract][Full Text] [Related]
49. Expression of the gene for arginine vasopressin in Brattleboro rats.
Fuller PJ; Clements JA; Lolait SJ; Lim AT; Johnston CI; Funder JW
J Hypertens Suppl; 1984 Dec; 2(3):S305-7. PubMed ID: 6400377
[TBL] [Abstract][Full Text] [Related]
50. The 5'-flanking region of human CD24 gene has cell-type-specific promoter activity in small-cell lung cancer.
Pass MK; Quintini G; Zarn JA; Zimmermann SM; Sigrist JA; Stahel RA
Int J Cancer; 1998 Nov; 78(4):496-502. PubMed ID: 9797140
[TBL] [Abstract][Full Text] [Related]
51. Effect of kappa opioid agonist RU 51599 on osmotic and non-osmotic stimulated arginine vasopressin release and gene regulation in small cell lung carcinoma cells.
Kim JK; Summer SN; Schrier RW
Neuropeptides; 1997 Oct; 31(5):423-9. PubMed ID: 9413018
[TBL] [Abstract][Full Text] [Related]
52. Gene regulation of vasopressin and vasopressin receptors in cancer.
North WG
Exp Physiol; 2000 Mar; 85 Spec No():27S-40S. PubMed ID: 10795904
[TBL] [Abstract][Full Text] [Related]
53. Transient gene expression in untransformed lymphocytes.
Mårtensson IL; Leanderson T
Eur J Immunol; 1987 Oct; 17(10):1499-502. PubMed ID: 3479332
[TBL] [Abstract][Full Text] [Related]
54. Cancer specificity of promoters of the genes controlling cell proliferation.
Kashkin K; Chernov I; Stukacheva E; Monastyrskaya G; Uspenskaya N; Kopantzev E; Sverdlov E
J Cell Biochem; 2015 Feb; 116(2):299-309. PubMed ID: 25187488
[TBL] [Abstract][Full Text] [Related]
55. Calcitonin elevation in small cell lung cancer without ectopic production.
Kelley MJ; Becker KL; Rushin JM; Venzon D; Phelps R; Ihde DC; Bliss DP; Melby K; Snider RH; Johnson BE
Am J Respir Crit Care Med; 1994 Jan; 149(1):183-90. PubMed ID: 8111580
[TBL] [Abstract][Full Text] [Related]
56. Differential expression of the antioxidant response element within the hNQO1 promoter in NSCLC versus SCLC.
Kepa JK; Ross D
Biochem Biophys Res Commun; 2003 Nov; 311(2):446-53. PubMed ID: 14592434
[TBL] [Abstract][Full Text] [Related]
57. Positive and negative regulators of the vasopressin gene promoter in small cell lung cancer.
Coulson JM
Prog Brain Res; 2002; 139():329-43. PubMed ID: 12436947
[No Abstract] [Full Text] [Related]
58. Regulation of FGF-3 gene expression in tumorigenic and non-tumorigenic clones of a human colon carcinoma cell line.
Galdemard C; Yamagata H; Brison O; Lavialle C
J Biol Chem; 2000 Jun; 275(23):17364-73. PubMed ID: 10749884
[TBL] [Abstract][Full Text] [Related]
59. Expression of the atrial natriuretic factor gene in small cell lung cancer tumors and tumor cell lines.
Bliss DP; Battey JF; Linnoila RI; Birrer MJ; Gazdar AF; Johnson BE
J Natl Cancer Inst; 1990 Feb; 82(4):305-10. PubMed ID: 2153841
[TBL] [Abstract][Full Text] [Related]
60. All three vasopressin receptor sub-types are expressed by small-cell carcinoma.
North WG; Fay MJ; Du J
Adv Exp Med Biol; 1998; 449():335-8. PubMed ID: 10026822
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
